Looking to publish in Thoracic Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowThoracic Cancer is an oncology journal that facilitates international collaboration of novel works on basic, translational and applied clinical research in lung, esophageal, mediastinal and breast cancer. Its content spans prevention, general thoracic surgery, medical oncology, radiology, radiation medicine, pathology, and translational studies in thoracic cancer, and it welcomes submissions on prevention, treatment, and research relevant to the Asia Pacific region.
Looking to publish in Thoracic Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Thoracic Cancer accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Reviews
Case Image
Clinical Guidelines
Letters To The Editor
Case Reports
Brief Reports
Recent Publications
Study on the Modes of Cell Death in Lung Cancer Epithelial Cells During Acute EBV Infection Using a Co‐Culture Model
Xinyue Zhang, Chenpeng Li, Shuilian Zhang, Wenqing Yan, Yu Chen, Danxia Lu, Zhi Xie, Pai Zhang, Xue Pan
Synergistic Antitumor Efficacy of Radiofrequency Ablation Combined With TROP2 ‐ CAR ‐T Cells in a Xenograft Mouse Model of Lung Adenocarcinoma
Yanyun Zhao, Peng Jiao, Zhuo Zhang, Yang Sun, Huiyan Sun, Xiaoguang Li, Zhixin Bie, Chenghua Xiao, Yanfei Qu, Wei Wang, Qinqin Xu, Lisheng Wang
Delayed Tumor Shrinkage Beyond Progressive Disease in Small‐Cell Lung Cancer Receiving Immunochemotherapy: A Case Report
Takahisa Kawamura, Kiyohide Komuta, Shun Futamura, Akito Miyazaki, Tsunehiro Tanaka, Kei Kunimasa, Takako Inoue, Motohiro Tamiya, Kazumi Nishino
Addition of Immune Checkpoint Inhibitor to Platinum Retreatment for Recurrent Non‐Small Cell Lung Cancer After Perioperative Chemotherapy: A Multicenter Retrospective Study
Toshiaki Takakura, Ryota Shibaki, Atsushi Washioka, Yusuke Murakami, Yuhei Harutani, Hiroaki Akamatsu, Nobuyuki Yamamoto
Tumor‐Bearing Status Accelerates Bleomycin‐Induced Pulmonary Inflammation via Endothelial Activation
Shoko Isoyama, Kakuhiro Yamaguchi, Hiroshi Iwamoto, Yasushi Horimasu, Kunihiko Funaishi, Kiyofumi Shimoji, Shinjiro Sakamoto, Takeshi Masuda, Taku Nakashima, Shinichiro Ohshimo, Hironobu Hamada, Noboru Hattori
Frequently asked questions
How long does it take to publish?
5 days submission to first decision (median).
Reformat to Thoracic Cancer using Livewrite PremiumIs a cover letter required?
A cover letter should be included in the Cover Letter Field of the Research Exchange system. It must confirm the paper has not been published or submitted elsewhere except as a brief abstract, acknowledge that all authors contributed significantly with each author's contribution described, and confirm that all authors agree with the manuscript content.
Reformat to Thoracic Cancer using Livewrite PremiumWhat are the publication costs?
An Article Publication Charge is required upon acceptance. The charge is waived for Editorials, Guidelines, Commentaries, Letter to the Editor, and Invited Reviews.
Reformat to Thoracic Cancer using Livewrite Premium